Activatable T 1 and T 2 Magnetic Resonance Imaging Contrast Agents

Abstract

Magnetic resonance imaging (MRI) has become one of the most important diagnosis tools available in medicine. Typically MRI is not capable of sensing biochemical activities. However, recently emerged activatable MRI contrast agents (CAs), whose relaxivity is variable in response to a specific parameter change in the surrounding physiological microenvironment, potentially allow for MRI to indicate biological processes. Among the various factors influencing the relaxivity of a CA, the number of inner-sphere water molecules (q) directly coordinated to the metal center, the residence time of the coordinated water molecule (τm), and the rotational correlation time representing the molecular tumbling time of a complex (τR) contribute strongly to the relaxivity of an activatable CA. Tuning the ligand structure and properties has been the subject of intensive research for activatable MR CA designs. This review summarizes a variety of activatable MRI CAs sensitive to common variables in microenvironment in vivo, i.e., pH, luminescence, metal ions, redox, and enzymes, etc., with emphasis on the influence of ligand design on parameters q, τm, and τR.

Size-Stable Solid Lipid Nanoparticles Loaded with Gd-DOTA for Magnetic Resonance Imaging

“…This is likely because the lipid-Gd-DPTA incorporated at the surface of the SLN such that the Gd-DPTA was accessible to the aqueous environment; in addition, tethering likely resulted in slowed rotational tumbling time for the tethered Gd-DTPA, which is known to increase relaxivity. 102,103 These observations are similar to a study where a lipid-Gd-DTPA molecule was incorporated on the surface of liposomes for use in T 1 w imaging applications. 62 These Gd-DTPA-liposomes were reported to have an r 1 value of 13.6 mM −1 s −1 at 3T (37°C) compared to free Gd-DTPA which has r 1 of 3.8 mM −1 s −1 at 3T (25°C).…”

Dendrimer-based magnetic resonance imaging agents for brain cancer

“…These agents, which are referred to stimulus-responsive or smart contrast agents, are sensitive to specific fluctuations in the local environment, such as pH, biological metal ion concentration or enzymatic activity, and are capable of reporting on such changes by inducing alterations in the MRI signal [119][120][121][122][123][124]. The change in relaxivity of these agents before and after stimulation is the most important factor in evaluating the efficiency of a stimulus-responsive contrast agent [125].…”

In Vivo 3T Magnetic Resonance Imaging Using a Biologically Specific Contrast Agent for Prostate Cancer: A Nude Mouse Model

“…Contrast agents in MRI change the signal intensity by altering the 1 and 2 relaxation times of tissues in the affected area [19,20]. By injecting contrast agents, the ability to differentiate tumours from surrounding tissue is increased, improving contrast and guidance of treatments.…”